{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:57:04Z","timestamp":1793987824960,"version":"4.8.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Multiple Endocrine Neoplasia type 1 is a rare genetic syndrome mainly caused by mutations of\n                      <jats:italic>MEN1<\/jats:italic>\n                      gene and characterized by a combination of several endocrine and non-endocrine manifestations. The objective of this study was to describe cutaneous lesions and other non-endocrine manifestations of\n                      <jats:italic>\n                        <jats:italic>MEN1<\/jats:italic>\n                      <\/jats:italic>\n                      in a cohort of patients with familial (F) and sporadic (S)\n                      <jats:italic>MEN1<\/jats:italic>\n                      , compare the prevalence of these manifestations between the two cohorts, and investigate the correlation with\n                      <jats:italic>\n                        <jats:italic>MEN1<\/jats:italic>\n                      <\/jats:italic>\n                      mutation status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We collected phenotypic and genotypic data of 185 patients with F-\n                      <jats:italic>MEN1<\/jats:italic>\n                      and S-\n                      <jats:italic>MEN1<\/jats:italic>\n                      followed from 1997 to 2022. The associations between F-\n                      <jats:italic>MEN1<\/jats:italic>\n                      and S-\n                      <jats:italic>MEN1<\/jats:italic>\n                      or\n                      <jats:italic>MEN1<\/jats:italic>\n                      mutation-positive and mutation-negative patients and non-endocrine manifestations were determined using chi-square or Fisher\u2019s exact tests or multivariate exact logistic regression analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of angiofibromas was significantly higher in F-\n                      <jats:italic>MEN1<\/jats:italic>\n                      than in S-\n                      <jats:italic>MEN1<\/jats:italic>\n                      in both the whole (p &amp;lt; 0.001) and index case (p = 0.003) cohorts. The prevalence of lipomas was also significantly higher in F-\n                      <jats:italic>MEN1<\/jats:italic>\n                      than in S-\n                      <jats:italic>MEN1<\/jats:italic>\n                      (p = 0.009) and in\n                      <jats:italic>MEN1<\/jats:italic>\n                      mutation-positive than in\n                      <jats:italic>MEN1<\/jats:italic>\n                      mutation-negative (p = 0.01) index cases. In the whole cohort, the prevalence of lipomas was significantly higher in\n                      <jats:italic>MEN1<\/jats:italic>\n                      mutation-positive compared to\n                      <jats:italic>MEN1<\/jats:italic>\n                      mutation-negative patients (OR = 2.7, p = 0.02) and in F-\n                      <jats:italic>MEN1<\/jats:italic>\n                      than in S-\n                      <jats:italic>MEN1<\/jats:italic>\n                      (p = 0.03), only after adjustment for age. No significant differences were observed for the other non-endocrine manifestations between the two cohorts. Hibernoma and collagenoma were each present in one patient (0.5%) and meningioma and neuroblastoma in 2.7% and 0.5%, respectively. Gastric leiomyoma was present in 1.1% of the patients and uterine leiomyoma in 14% of women. Thyroid cancer, breast cancer, lung cancer, basal cell carcinoma, melanoma, and colorectal cancer were present in 4.9%, 2.7%, 1.6%, 1.6%, 2.2%, and 0.5% of the whole series, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We found a significantly higher prevalence of angiofibromas and lipomas in F-\n                      <jats:italic>MEN1<\/jats:italic>\n                      compared with S-\n                      <jats:italic>MEN1<\/jats:italic>\n                      and in\n                      <jats:italic>MEN1<\/jats:italic>\n                      mutation-positive compared to\n                      <jats:italic>\n                        <jats:italic>MEN1<\/jats:italic>\n                      <\/jats:italic>\n                      mutation-negative patients. In patients with one major endocrine manifestation of\n                      <jats:italic>\n                        <jats:italic>MEN1<\/jats:italic>\n                      <\/jats:italic>\n                      , the presence of cutaneous lesions might suggest the diagnosis of\n                      <jats:italic>\n                        <jats:italic>MEN1<\/jats:italic>\n                      <\/jats:italic>\n                      and a possible indication for genetic screening.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1191040","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T07:40:10Z","timestamp":1688715610000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Laura","family":"Pierotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Dinoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Piaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Borsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Della Valentina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adelaide","family":"Caligo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Bogazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186485","article-title":"Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features","volume":"12","author":"Pardi","year":"2017","journal-title":"PloS One"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209400","article-title":"Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression","volume":"25","author":"La","year":"2006","journal-title":"Oncogene"},{"key":"B4","first-page":"37","article-title":"Cellular functions of menin","volume-title":"SuperMEN1. Advances in experimental medicine and biology","author":"Hendy","year":"2009"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2010.04.011","article-title":"Menin dynamics and functional insight: take your partners","volume":"326","author":"Balogh","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0195","article-title":"Multiple endocrine neoplasia type 1 in northern finland; clinical features and genotype\u2013phenotype correlation","volume":"157","author":"Vierimaa","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-01932-x","article-title":"True MEN1 or phenocopy? evidence for geno-phenotypic correlations in MEN1 syndrome","volume":"65","author":"K\u00f6vesdi","year":"2019","journal-title":"Endocrine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198907273210403","article-title":"Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11","volume":"321","author":"Thakker","year":"1989","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3803\/EnM.2014.29.3.270","article-title":"Genetic and epigenetic analysis in Korean patients with multiple endocrine neoplasia type 1","volume":"29","author":"Chung","year":"2014","journal-title":"Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.557050","article-title":"Prevalence of parathyroid carcinoma and atypical parathyroid neoplasms in 153 patients with multiple endocrine neoplasia type 1: case series and literature review","volume":"11","author":"Song","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00966.x","article-title":"Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1","volume":"52","author":"Hai","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21170","article-title":"Diagnostic challenges due to phenocopies: lessons from multiple endocrine neoplasia type1 (MEN1)","volume":"31","author":"Turner","year":"2010","journal-title":"Hum Mutat"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/EJE-19-0522","article-title":"Whole genome sequencing of apparently mutation-negative MEN1 patients","volume":"182","author":"Backman","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890430067009","article-title":"Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1","volume":"133","author":"Darling","year":"1997","journal-title":"Arch Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02578.x","article-title":"Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1","volume":"22","author":"Vidal","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0218","article-title":"Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1","volume":"89","author":"Asgharian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18327","article-title":"Dermatologic manifestations of endocrine disorders","volume":"27","author":"Raj","year":"2021","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00140.x","article-title":"Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene","volume":"110","author":"Pack","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.47.569","article-title":"Frequency of facial angiofibromas in Japanese patients with multiple endocrine neoplasia type 1","volume":"47","author":"Sakurai","year":"2000","journal-title":"Endocr J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1507\/endocrine1927.67.7_764","article-title":"Clinical characteristics in multiple endocrine neoplasia type 1 in Japan: a review of 106 patients","volume":"67","author":"Yoshimoto","year":"1991","journal-title":"Folia Endocrinol Jpn"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3690","article-title":"MEN1-dependent breast cancer: indication for early screening? results from the Dutch MEN1 study group","volume":"102","author":"van Leeuwaarde","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2144","article-title":"Multiple endocrine neoplasia type 1 associated with breast cancer","volume":"1","author":"Jeong","year":"2014","journal-title":"A Case Rep Rev literature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02340","article-title":"Recent topics around multiple endocrine neoplasia type 1","volume":"103","author":"Marx","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1016\/B978-032303004-5.50153-8","article-title":"Lumps and bumps: benign and malignant tumors","volume-title":"Comprehensive pediatric hospital medicine","author":"Roberts","year":"2007"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1007\/3-540-28043-X_71","article-title":"Lipomas treated with liposuction","volume-title":"Liposuction","author":"Mancoll","year":"2006"},{"key":"B32","article-title":"Lipoma excision","volume":"65","author":"Salam","year":"2002","journal-title":"Am Fam Physician"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200106000-00014","article-title":"The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases","volume":"25","author":"Furlong","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2015.05.022","article-title":"Leiomyomas in the gastric cardia: CT findings and differentiation from gastrointestinal stromal tumors","volume":"84","author":"Yang","year":"2015","journal-title":"Eur J Radiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4029","article-title":"Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas","volume":"98","author":"Pardi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65289-3","article-title":"Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms","volume":"154","author":"G\u00f6rtz","year":"1999","journal-title":"Am J Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/humu.10092","article-title":"Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein","volume":"20","author":"Wautot","year":"2002","journal-title":"Hum Mutat"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.3390\/diagnostics12112768","article-title":"Approach of multiple endocrine neoplasia type 1 (MEN1) syndrome\u2013related skin tumors","volume":"12","author":"B\u0103icoianu-Ni\u0163escu","year":"2022","journal-title":"Diagnostics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1029041","article-title":"Beyond the \u201c3 ps\u201d: a critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1","volume":"13","author":"Waguespack","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2011.03.006","article-title":"Combined characterization of a pituitary adenoma and a subcutaneous lipoma in a MEN1 patient with a whole gene deletion","volume":"204","author":"Rusconi","year":"2011","journal-title":"Cancer Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01414-2","article-title":"Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: do they have a relationship with the prognosis of these patients","volume":"44","author":"Febrero","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0938-8","article-title":"Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients","volume":"13","author":"Marini","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00005792-196407000-00003","article-title":"Familial multiple endocrine adenoma-peptic ulcer complex","volume":"43","author":"Ballard","year":"1964","journal-title":"Med (Baltimore)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/149826","article-title":"Consequence of menin deficiency in mouse adipocytes derived by In vitro differentiation","volume":"2015","author":"Parekh","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1)","volume":"89","author":"Trump","year":"1996","journal-title":"QJM"},{"key":"B47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and zollinger-Ellison syndrome","volume":"83","author":"Gibril","year":"2004","journal-title":"Med (Baltimore)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1086\/301729","article-title":"Characterization of mutations in patients with multiple endocrine neoplasia type 1","volume":"62","author":"Bassett","year":"1998","journal-title":"Am J Hum Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/archsurg.137.6.641","article-title":"Genotype-phenotype analysis in multiple endocrine neoplasia type 1","volume":"137","author":"Kouvaraki","year":"2002","journal-title":"Arch Surg"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1067\/msy.1998.93107","article-title":"The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1","volume":"124","author":"Carty","year":"1998","journal-title":"Surgery"},{"key":"B51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1530\/EJE-12-0457","article-title":"Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues","volume":"168","author":"Oriola","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2291","article-title":"Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients","volume":"97","author":"Cazabat","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04445.x","article-title":"Familial pituitary adenomas - who should be tested for AIP mutations","volume":"77","author":"Korbonits","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0778","article-title":"Germline and somatic mosaicism in a family with multiple endocrine neoplasia type 1 (MEN1) syndrome","volume":"180","author":"Beijers","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0093","article-title":"Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms","volume":"11","author":"Lagarde","year":"2022","journal-title":"Endocr Connect"},{"key":"B56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1530\/EJE-18-0430","article-title":"Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencing","volume":"179","author":"Carvalho","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14060","article-title":"Clinical and histopathological evaluation of cutaneous angiofibromas","volume":"48","author":"Nasimi","year":"2021","journal-title":"J Cutan Pathol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2022.11.003","article-title":"Adrenal liposarcoma: a novel presentation of multiple endocrine neoplasia type 1","volume":"9","author":"Duro","year":"2023","journal-title":"AACE Clin Case Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196712282772601","article-title":"Clinical and genetic investigation of a Large kindred with multiple endocrine adenomatosis","volume":"277","author":"Johnson","year":"1967","journal-title":"N Engl J Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.5.3944","article-title":"Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1","volume":"82","author":"Dong","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2013.02.002","article-title":"Hibernoma: don\u2019t be caught out by a PET scan","volume":"94","author":"Ognong Boulemo","year":"2013","journal-title":"Diagn Interv Imaging"},{"key":"B62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ando.2013.03.013","article-title":"Hibernoma and type 1 multiple endocrine neoplasia (MEN1)? a metabolic link","volume":"74","author":"Karrouz","year":"2013","journal-title":"Ann Endocrinol (Paris)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/804580","article-title":"MEN1 syndrome and hibernoma: an uncommonly recognised association","volume":"2014","author":"Hedayati","year":"2014","journal-title":"Case Rep Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2017.03.001","article-title":"Hibernoma and multiple endocrine neoplasia type 1 syndrome: a non-fortuitous association? a case report and literature review","volume":"78","author":"Marchand","year":"2017","journal-title":"Ann Endocrinol (Paris)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2020.11.073","article-title":"Axillary hibernoma in woman with lobular breast cancer and MEN1 syndrome: a case report","volume":"77","author":"Deguidi","year":"2020","journal-title":"Int J Surg Case Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65099-7","article-title":"Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region","volume":"155","author":"Gisselsson","year":"1999","journal-title":"Am J Pathol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013512107","article-title":"Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma","volume":"107","author":"Nord","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/path.4945","article-title":"Loss of the tumor suppressor gene AIP mediates the browning of human brown fat tumors","volume":"243","author":"Magnusson","year":"2017","journal-title":"J Pathol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00167-13","article-title":"MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair","volume":"33","author":"Fang","year":"2013","journal-title":"Mol Cell Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20000815)87:4<463::AID-IJC1>3.0.CO;2-8","article-title":"Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma","volume":"87","author":"Nord","year":"2000","journal-title":"Int J Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-0938-3","article-title":"Meningiomas may be a component tumor of multiple endocrine neoplasia type 1","volume":"10","author":"Asgharian","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/02688698909001027","article-title":"The coexistence of pituitary adenomas and meningiomas: three case reports and a review of the literature","volume":"3","author":"Honegger","year":"1989","journal-title":"Br J Neurosurg"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2390797","article-title":"Coexistence of GH-producing pituitary macroadenoma and meningioma in a patient with multiple endocrine neoplasia type 1 with hyperglycemia and ketosis as first clinical sign","volume":"2017","author":"Herrero-Ruiz","year":"2017","journal-title":"Case Rep Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11601","article-title":"Germline mutations in MEN1 are associated with the tumorigenesis of pituitary adenoma associated with meningioma","volume":"20","author":"Zhu","year":"2020","journal-title":"Oncol Lett"},{"key":"B75","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","article-title":"Uterine fibroids","volume":"2","author":"Stewart","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"B76","article-title":"Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors","volume":"12","author":"Vortmeyer","year":"1999","journal-title":"Mod Pathol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61788-9","article-title":"Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1","volume":"159","author":"McKeeby","year":"2001","journal-title":"Am J Pathol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Day Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s002680010237","article-title":"Are patients with multiple endocrine neoplasia type I prone to premature death","volume":"24","author":"Dean","year":"2000","journal-title":"World J Surg"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1406028","article-title":"Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1191040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T07:40:17Z","timestamp":1688715617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1191040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":81,"alternative-id":["10.3389\/fendo.2023.1191040"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1191040","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"article-number":"1191040"}}